Bentham Science Logo

New Emirates Medical Journal

Volume 3, 2 Issues, 2022
ISSN: 0250-6882 (Online)
This journal supports open access

Track Your Manuscript:


Open Access Article

Systemic Treatments for Adult Patients with Moderate-to-Severe Psoriasis: Consensus Statements for the United Arab Emirates



Anwar Al Hammadi1, *, Muna Al Murrawi2, Huda R. Ali3, Ashraf M. Reda4, Hussein A. Dayem5, Jawaher Alnaqbi6, Zaidoon Abdelhadi7, Samir Hantirah8, Ayman Alnaeem9, Fatima Al. Marzooqi10, Amani Alfalasi11, Fatima Albreiki12, Khadija Aljefri1, Faiza Al Ali13
1 DermaMed Clinic, Dubai, UAE
2 Dr. Muna Al murrawi Medical Center, Abu Dhabi, UAE
3 SEHA – Ambulatory Healthcare Services, Al Maqtaa Healthcare Center, Abu Dhabi, UAE
4 Mediclinic Welcare Hospital, Dubai, UAE
5 Mediclinic Al Noor Hospital, Abu Dhabi, UAE
6 Fujairah Hospital, Ministry of Health and Prevention, Fujairah, UAE
7 Sheikh Khalifa Medical City, Abu Dhabi, UAE
8 American Hospital, Dubai, UAE
9 Ibrahim Bin Hamad Obaidullah Hospital, Emirates Health Services Establishment, Ras al Khaimah, UAE
10 Zayed Military Hospital, Abu Dhabi, UAE
11 Rashid Hospital, Dubai Health Authority, Dubai, UAE
12 Tawam Hospital, Abu Dhabi, UAE
13 Al-Qassimi Hospital, Ministry of Health and Prevention, Sharjah, UAE

Abstract

Background:

Psoriasis is a chronic, immune-mediated disease characterized by mild localized plaques to severe plaques involving any part of the skin; it has a pronounced effect on patients’ quality of life. In the United Arab Emirates (UAE), there are limited local guidelines for the management of patients with psoriasis in daily clinical practice.

Objectives:

The study aimed to develop consensus statements for the evaluation and management of moderate-to-severe psoriasis in the UAE.

Methods:

To develop consensus statements, the Emirates Dermatology Society set up advisory board meetings in which local key opinion leaders (KOLs), including dermatologists from the UAE, participated. A targeted literature review was conducted to review current international and regional guidelines on the management of psoriasis, based on which the statements were formulated. A final consensus on each statement was reached based on collective agreement among the KOLs.

Results:

Consensus statements were generated with the intention of supporting physicians in clinical decision-making with respect to the classification of disease severity, treatment options including biologic and non-biologic systemic therapies, transitioning and adjusting of systemic therapies, and monitoring and management of psoriasis in special populations.

Conclusion:

These consensus statements could provide useful, practical guidance on the diagnosis and management of patients with moderate-to-severe psoriasis and would cater to the needs of physicians in the UAE.

Keywords: Psoriasis, Consensus statement, Dermatology, Medication therapy management, Non-biologic therapy, Biologic therapy.


Article Information


Identifiers and Pagination:

Year: 2022
Volume: 3
Issue: 1
First Page: 17
Last Page: 34
Publisher Id: nemj-3-17
DOI: 10.2174/02666211213145047

Article History:

Received Date: 02/08/2021
Revision Received Date: 25/10/2021
Acceptance Date: 31/10/2021
Electronic publication date: 21/01/2022
Collection year: 2022

© 2022 Al Hammadi et al.

open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


* Address correspondence to this author at the DermaMed Clinic, Dubai, UAE; Tel: +971 4 385 2222; E-mail: skinest@hotmail.com





Editor-in-Chief

Abdullah Shehab
Emirates Cardiac Society
Emirates Medical Association
Dubai
(United Arab Emirates)
Biography
View Full Editorial Board

Annual Journal Metrics

Speed

Acceptance rate = 40%

Average review speed: 45 days average

18 days from acceptance to publication